BeOne Medicines AG

ONC · Healthcare · BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States,…

BeOne Medicines AG (ONC), in the Healthcare sector, has 41 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 0 purchases and 41 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 10. The most active filer was Chan Henry Lee with 20 filings.

Add to watchlist

Filings, ttm

0 buys · 41 sells

Traders, ttm

7 insiders

Volume, ttmiDollar value disclosed in the window

$359.5M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 8

Filed Sep 10

ADViAverage daily dollar volume

$130.5M

market data

Share price · 12M

$363 (+7.4%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $621.9M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Chan Henry Lee SVP, General Counsel 20 filings JO

John Oyler Chief Executive Officer 16 filings XW

Xiaobin Wu President, COO & GM China 11 filings LW

Lai Wang President, Global Head of R&D 10 filings AR

Aaron Rosenberg Chief Financial Officer 3 filings XW Xiaodong Wang Director 3 filings CS

Corazon (Corsee) D. Sanders Director 2 filings BL Baker Bros. Advisors (GP) LLC Director 1 filing

Recent filings

Xiaodong WangSALE Director $13.4M
38,287 sh across 8 lots
Exec Sep 8
Filed Sep 10 · 4:49 PM ET Xiaobin WuSALE President and COO $106K
280 sh × $380.00
Exec Aug 25
Filed Aug 27 · 5:12 PM ET Chan Henry LeeSALE SVP, General Counsel $960K
2,666 sh × $360.00
Exec Aug 11
Filed Aug 13 · 8:54 PM ET John OylerSALE Chief Executive Officer $86.5M
240,739 sh across 22 lots
Exec Aug 10
Filed Aug 12 · 5:53 PM ET Aaron RosenbergSALE Chief Financial Officer $362K
1,157 sh × $312.71
Exec Aug 3
Filed Aug 5 · 5:15 PM ET Chan Henry LeeSALE SVP, General Counsel $338K
1,044 sh × $323.69
Exec Jul 30
Filed Aug 3 · 5:18 PM ET Chan Henry LeeSALE SVP, General Counsel $542K
1,669 sh × $325.00
Exec Jul 22
Filed Jul 24 · 4:51 PM ET John OylerSALE Chief Executive Officer $34.5M
109,433 sh across 13 lots
Exec Jul 20
Filed Jul 22 · 5:03 PM ET John OylerSALE Chief Executive Officer $20.1M
64,577 sh across 8 lots
Exec Jul 17
Filed Jul 17 · 5:36 PM ET John OylerSALE Chief Executive Officer $89.3M
282,921 sh across 16 lots
Exec Jul 15
Filed Jul 17 · 5:31 PM ET John OylerSALE Chief Executive Officer $44.6M
145,861 sh across 6 lots
Exec Jul 14
Filed Jul 14 · 9:26 PM ET John OylerSALE Chief Executive Officer $18.1M
59,594 sh across 11 lots
Exec Jul 10
Filed Jul 14 · 9:25 PM ET Chan Henry LeeSALE SVP, General Counsel $201K
664 sh × $302.46
Exec Jul 8
Filed Jul 10 · 4:44 PM ET Lai WangSALE President, Global Head of R&D $296K
1,068 sh × $276.74
Exec Jun 23
Filed Jun 25 · 5:30 PM ET John OylerSALE Chief Executive Officer $846K
3,090 sh across 2 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET Xiaobin WuSALE President and COO $357K
1,292 sh × $276.26
Exec Jun 23
Filed Jun 25 · 5:30 PM ET Lai WangSALE President, Global Head of R&D $310K
1,169 sh × $265.39
Exec Jun 16
Filed Jun 18 · 5:30 PM ET Chan Henry LeeSALE SVP, General Counsel $157K
590 sh × $265.98
Exec Jun 16
Filed Jun 18 · 5:30 PM ET John OylerSALE Chief Executive Officer $892K
3,360 sh across 2 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET Xiaobin WuSALE President and COO $362K
1,357 sh × $266.76
Exec Jun 16
Filed Jun 18 · 5:30 PM ET John OylerSALE Chief Executive Officer $411K
1,600 sh across 2 lots
Exec Jun 11
Filed Jun 15 · 5:30 PM ET Chan Henry LeeSALE SVP, General Counsel $110K
428 sh × $257.64
Exec Jun 11
Filed Jun 15 · 5:30 PM ET Xiaobin WuSALE President and COO $164K
626 sh × $261.20
Exec Jun 11
Filed Jun 15 · 5:30 PM ET Aaron RosenbergSALE Chief Financial Officer $163K
631 sh × $257.74
Exec Jun 11
Filed Jun 15 · 5:30 PM ET Lai WangSALE President, Global Head of R&D $197K
756 sh × $261.00
Exec Jun 11
Filed Jun 15 · 5:30 PM ET